Finance

Lists
301111:SHE
Guangdong Lifestrong Pharmacy Co Ltd
CNÂ¥22.46
-1.71%
(-0.39) 1D
Sep 8, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301111...
Open
CNÂ¥22.87
High
CNÂ¥22.94
Low
CNÂ¥22.27
Mkt. cap
3.60B
Avg. vol.
6.86M
Volume
5.40M
Dividend
0.22%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 11, 2026
P/E ratio
606.21
52-wk high
CNÂ¥31.36
52-wk low
CNÂ¥15.08
EPS
CNÂ¥0.04
Shares outstanding
160.00M
No. of employees
578
Open
CNÂ¥22.87
High
CNÂ¥22.94
Low
CNÂ¥22.27
Mkt. cap
3.60B
Avg. vol.
6.86M
Volume
5.40M
Dividend
0.22%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 11, 2026
P/E ratio
606.21
52-wk high
CNÂ¥31.36
52-wk low
CNÂ¥15.08
EPS
CNÂ¥0.04
Shares outstanding
160.00M
No. of employees
578
About Guangdong Lifestrong Pharmacy Co Ltd
CEO-
Employees578
Founded1951
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
73.63M
86.22M
66.18M
78.58M
Cost of goods sold
31.06M
36.43M
31.38M
30.54M
Cost of revenue
31.06M
36.43M
31.38M
30.54M
Research and development expenses
2.79M
1.81M
1.97M
2.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.36M
47.41M
37.19M
38.40M
Operating expense
46.79M
50.15M
39.78M
41.48M
Total operating expenses
77.84M
86.58M
71.16M
72.02M
Operating income
-4.21M
-359.47K
-4.98M
6.56M
Other non operating income
-337.45K
329.02K
-25.51K
582.71K
EBT including unusual items
-2.77M
5.12M
-3.40M
6.80M
EBT excluding unusual items
-3.13M
8.48M
-3.94M
7.80M
Income tax expense
-1.37M
2.68M
203.50K
1.17M
Effective tax rate
49.30%
52.35%
-5.98%
17.16%
Other operating expenses
1.00M
1.12M
930.09K
641.77K
Net income
-904.65K
3.64M
-3.31M
6.50M
Net profit margin
-1.23%
4.22%
-5.00%
8.27%
Earnings per share
-
-
-
-
Interest and investment income
1.87M
9.55M
1.52M
662.67K
Interest expense
-447.46K
-1.04M
-461.27K
-
Net interest expenses
1.42M
8.51M
1.06M
662.67K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.53M
2.08M
-2.53M
8.95M
Gain or loss from assets sale
-
-
-
-16.81K
AI content may include mistakes. Learn more
Google apps